Pathogenic role of Fgf23 in Hyp mice - PubMed (original) (raw)
. 2006 Jul;291(1):E38-49.
doi: 10.1152/ajpendo.00008.2006. Epub 2006 Jan 31.
Affiliations
- PMID: 16449303
- DOI: 10.1152/ajpendo.00008.2006
Free article
Pathogenic role of Fgf23 in Hyp mice
Shiguang Liu et al. Am J Physiol Endocrinol Metab. 2006 Jul.
Free article
Abstract
Inactivating mutations of the PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) endopeptidase, the disease-causing gene in X-linked hypophosphatemia (XLH), results in increased circulating levels of fibroblastic growth factor-23 (FGF23), a bone-derived phosphaturic factor. To determine the causal role of FGF23 in XLH, we generated a combined Fgf23-deficient enhanced green fluorescent protein (eGFP) reporter and Phex-deficient Hyp mouse model (Fgf23(+/-)/Hyp). eGFP expression was expressed in osteocytes embedded in bone that exhibited marked upregulation of eGFP in response to Phex deficiency and in CD31-positive cells in bone marrow venules that expressed low eGFP levels independently of Phex. In bone marrow stromal cells (BMSCs) derived from Fgf23(-/-)/Hyp mice, eGFP expression was also selectively increased in osteocyte-like cells within mineralization nodules and detected in low levels in CD31-positive cells. Surprisingly, eGFP expression was not increased in cell surface osteoblasts, indicating that Phex deficiency is necessary but not sufficient for increased Fgf23 expression in the osteoblast lineage. Additional factors, associated with either osteocyte differentiation and/or extracellular matrix, are necessary for Phex deficiency to stimulate Fgf23 gene transcription in bone. Regardless, the deletion of Fgf23 from Hyp mice reversed the hypophosphatemia, abnormal 1,25(OH)(2)D(3) levels, rickets, and osteomalacia associated with Phex deficiency. These results suggest that Fgf23 acts downstream of Phex to cause both the renal and bone phenotypes in Hyp mice.
Similar articles
- Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S, Tang W, Zhou J, Vierthaler L, Quarles LD. Liu S, et al. Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1636-44. doi: 10.1152/ajpendo.00396.2007. Epub 2007 Sep 11. Am J Physiol Endocrinol Metab. 2007. PMID: 17848631 - Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.
Yuan B, Takaiwa M, Clemens TL, Feng JQ, Kumar R, Rowe PS, Xie Y, Drezner MK. Yuan B, et al. J Clin Invest. 2008 Feb;118(2):722-34. doi: 10.1172/JCI32702. J Clin Invest. 2008. PMID: 18172553 Free PMC article. - Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
Martin A, Liu S, David V, Li H, Karydis A, Feng JQ, Quarles LD. Martin A, et al. FASEB J. 2011 Aug;25(8):2551-62. doi: 10.1096/fj.10-177816. Epub 2011 Apr 20. FASEB J. 2011. PMID: 21507898 Free PMC article. - FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
Quarles LD. Quarles LD. Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E1-9. doi: 10.1152/ajpendo.00016.2003. Am J Physiol Endocrinol Metab. 2003. PMID: 12791601 Review. - The wrickkened pathways of FGF23, MEPE and PHEX.
Rowe PS. Rowe PS. Crit Rev Oral Biol Med. 2004 Sep 1;15(5):264-81. doi: 10.1177/154411130401500503. Crit Rev Oral Biol Med. 2004. PMID: 15470265 Free PMC article. Review.
Cited by
- The role of GDF5 in regulating enthesopathy development in the Hyp mouse model of XLH.
Sorsby M, Almardini S, Alayyat A, Hughes A, Venkat S, Rahman M, Baker J, Rana R, Rosen V, Liu ES. Sorsby M, et al. J Bone Miner Res. 2024 Aug 21;39(8):1162-1173. doi: 10.1093/jbmr/zjae086. J Bone Miner Res. 2024. PMID: 38836497 - Periparturient Mineral Metabolism: Implications to Health and Productivity.
Vieira-Neto A, Lean IJ, Santos JEP. Vieira-Neto A, et al. Animals (Basel). 2024 Apr 19;14(8):1232. doi: 10.3390/ani14081232. Animals (Basel). 2024. PMID: 38672379 Free PMC article. Review. - Impaired Growth Plate Maturation in XLH Is due to Both Excess FGF23 and Decreased 1,25-Dihydroxyvitamin D Signaling.
Yadav PS, Kobelski MM, Martins JS, Tao T, Liu ES, Demay MB. Yadav PS, et al. Endocrinology. 2023 Nov 20;165(1):bqad186. doi: 10.1210/endocr/bqad186. Endocrinology. 2023. PMID: 38066669 - FGF23 directly inhibits osteoprogenitor differentiation in Dmp1-knockout mice.
Courbon G, Kentrup D, Thomas JJ, Wang X, Tsai HH, Spindler J, Von Drasek J, Ndjonko LM, Martinez-Calle M, Lynch S, Hivert L, Wang X, Chang W, Feng JQ, David V, Martin A. Courbon G, et al. JCI Insight. 2023 Dec 22;8(24):e156850. doi: 10.1172/jci.insight.156850. JCI Insight. 2023. PMID: 37943605 Free PMC article. - Modeling of intramembranous ossification using human pluripotent stem cell-derived paraxial mesoderm derivatives.
Ikeda Y, Tani S, Moriishi T, Kuroda A, Matsuo Y, Saeki N, Inui-Yamamoto C, Abe M, Maeda T, Rowe DW, Chung UI, Hojo H, Matsushita Y, Sawase T, Ohba S. Ikeda Y, et al. Regen Ther. 2023 Oct 10;24:536-546. doi: 10.1016/j.reth.2023.09.017. eCollection 2023 Dec. Regen Ther. 2023. PMID: 37860130 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials